Amcasertib

N/A

Report date: 2025/06/05 20:00:13
NME

Base Information

Drug NameAmcasertib
Drug Alias NameBB-503GB-503BBI-503
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein phosphatase inhibitors
TargetsSerine/threonine-protein phosphatase
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsCarcinoma, Transitional Cell +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBoston Biomedical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian NeoplasmsCarcinoma, Transitional Cell +[8

Other Information

ATC CodeN/A
Related LinksN/A